SEARCH

SEARCH BY CITATION

References

  • 1
    Perterson RO. Renal pelvis. In: Biello LA (ed.). Urologic Pathology. Lippincott, Philadelphia, 1986; 181– 228.
  • 2
    Kinder CH & Wallace DM. Recurrent carcinoma in the ureteric stump. Br. J. Surg. 1962; 50: 202 5.
  • 3
    Strong DW & Pearse HD. Recurrent ureteral tumors following surgery for transitional cell carcinoma of the upper urinary tract. Cancer 1976; 38: 2178 83.
  • 4
    Bloom NA, Vidone RA, Lytone B. Primary carcinoma of the ureter: A report of 102 new cases. J. Urol. 1970; 103: 590–8.
  • 5
    Latham HS & Kays S. Malignant tumors of the pelvis. Surg. Gynecol. Obstet. 1974; 138: 613 22.
  • 6
    Japanese Urological and Pathological Association. General Rules for Clinical and Pathological Studies on Renal Pelvic and Ureteral Cancers, 1st. edn. Kanehara, Tokyo, 1990.
  • 7
    Tawfiek ER & Bagley DH. Upper-tract transitional cell carcinoma. Urology 1997; 50: 321 9.
  • 8
    Matsuoka K & Noda S. Endoscopic treatment of upper urinary tract tumors. Jpn. J. Clin. Urol. 1998; 52: 373 80.
  • 9
    Wallace DMA, Wallace DM, Whitfield HN, Hendry WF, Wickham JEA. The late results of conservative surgery for upper tract urothelial carcinomas. Br. J. Urol. 1981; 53: 537 41.
  • 10
    Murphy DM, Zincke H, Furlow WL. Primary grade 1 transitional cell carcinoma of the renal pelvis and ureter. J. Urol. 1980; 123: 629 31.
  • 11
    Mufti GR, Gove JRW, Badenoch DF et al. Transitional cell carcinoma of the renal pelvis and ureter. Br. J. Urol. 1989; 63: 135 40.
  • 12
    Zerotic S & Gonzales J. Primary carcinoma of ureters. Urology 1983; 21: 354 6.
  • 13
    Leitenberger A, Beyer A, Altwein JE. Organ-sparing treatment for ureteral carcinoma? Eur. Urol. 1996; 29: 272 8.
  • 14
    Zungri E, Chechile G, Algaba F, Diaz I, Vila F, Castiro C. Treatment of transitional cell carcinoma of the ureter: Is the controversy justified? Eur. Urol. 1990; 17: 276 80.
  • 15
    Murphy DM, Zincke H, Furlow WL. Management of high grade transitional cell cancer of the upper urinary tract. J. Urol. 1981; 125: 25 9.
  • 16
    Heney NM, Nocks BN, Daly JJ, Blitzer PH, Parkhurst EC. Prognostic factors in carcinoma of the ureter. J. Urol. 1981; 125: 632 6.
  • 17
    Keely FX, Kulp DA, Bibbo M, McCue PA, Bagley DH. Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma. J. Urol. 1997; 157: 33 7.
  • 18
    Bazeed MA, Schaerfe T, Becht E, Alken P, Thueroff JW. Local excision of urothelial cancer of the upper urinary tract. Eur. Urol. 1986; 12: 89 95.
  • 19
    Anderstroem C, Johansson SL, Pettersson S, Wahlqvist L. Carcinoma of the ureter: A clinicopathologic study of 49 cases. J. Urol. 1989; 142: 280 3.
  • 20
    Johanson DE & Babaian RJ. Conservative surgical management for non-invasive distal ureteral carcinoma. Urology 1979; 13: 365 7.
  • 21
    Mazeman E. Tumors of the upper urinary tract calyces, renal pelvis and ureter. Eur. Urol. 1976; 2: 120 6.
  • 22
    Zincke H & Neves RJ. Feasibility of conservative surgery for transitional cell cancer of the upper urinary tract. Urol. Clin. North Am. 1984; 11: 717 24.
  • 23
    Keely FX, Bibbo M, Bagley DH. Ureteroscopic treatment and surveillance of upper urinary tract transitional cell carcinoma. J. Urol. 1997; 157: 1560 5.
  • 24
    McCarron JpJr, Chasko SB, Gray GfJr. Systematic mapping of nephroureterectomy specimens removed for urothelial cancer: Pathological findings and clinical correlations. J. Urol. 1982; 128: 243 6.
  • 25
    Martinez-Pineiro JA, Garcia Matres MJ, Martinez-Pineiro L. Endourological treatment of upper tract urothelial carcinomas: Analysis of a series of 59 tumors. J. Urol. 1996; 156: 377 85.
  • 26
    Studer UE, Casanova G, Kraft R, Zingg EJ. Percutaneous bacillus Calmette-Guerin perfusion of upper urinary tract for carcinoma in situ. J. Urol. 1989; 142: 975 7.
  • 27
    Eastman JA & Huffman JL. Technique of mitomycin C following endoscopic treatment of upper urinary tract urothelial tumors. J. Urol. 1993; 150: 324 5.